PharmEasy, one of India’s leading online pharmacy platforms, is undergoing a significant leadership shift that could shape its future trajectory. In a move that surprised many, three of its founding members have stepped back from day-to-day operations to explore new opportunities, while Siddharth Shah, the company’s fourth co-founder, is now at the helm. Here’s a breakdown of what this…
PharmEasy, once a shining star in India’s healthtech industry with a $5.6 billion valuation, has seen a dramatic drop in its worth, now valued at just $456 million. This steep decline has come to light after investor Janus Henderson disclosed it had significantly reduced the value of its shares in PharmEasy. What caused this sharp drop, and what does the future hold for the online pharmacy?
Accel, the prominent global venture capital firm, is reportedly in advanced discussions to lead a funding round of $30 million to $40 million in Truemeds, an innovative Indian online pharmacy focused on making healthcare more accessible through affordable generic medications. According to multiple sources familiar with the negotiations, the proposed valuation for the six-year-old startup stands at…
